Search - tctmd.com

Displaying 21 - 40 of 186

Sort: Relevancy | Date

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT Abstracts 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

Presentation TCT 2024

TCT 467: Prolonged Occlusion of the Superior Vena Cava Using the PreCardia System Reduces Cardiac Filling and Renal Venous Pressures Without Causing Cerebral Injury in a Preclinical Model of Systemic Congestion

Presenter: Navin Kapur

October 28, 2024

Presentation TCT 2024

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

Presenter: Tomasz Skowerski

October 28, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

Todd Neale

July 19, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Conference News ESC Heart Failure 2024

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Michael O'Riordan

May 13, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Advertisement

When to Use Devices the Recude Renal Vein Pressure

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

TCTMD’s Top 10 Most Popular Stories for December 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

TCT 467: Prolonged Occlusion of the Superior Vena Cava Using the PreCardia System Reduces Cardiac Filling and Renal Venous Pressures Without Causing Cerebral Injury in a Preclinical Model of Systemic Congestion

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

August 2024 Dispatch for the CV Team

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Kidney Events High in Older Patients After HF Hospitalization

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Semaglutide Winning Streak Continues in CKD With FLOW

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content